Press release
Allergic Conjunctivitis - Drug Pipeline Landscape, 2023 | Aldeyra Therapeutics, Allakos, Inmunotek, Regeneron Pharmaceuticals
Allergic conjunctivitis is inflammation of the conjunctiva caused by an allergic reaction. Allergic conjunctivitis is caused by allergens and irritants, such as pollen, dust and mold. Allergic conjunctivitis can be grouped into two types seasonal allergic conjunctivitis and perennial allergic conjunctivitis.To Remain 'Ahead' Of Your Competitors, Request for A Sample: https://www.globalinsightservices.com/request-sample/GIS31211
Symptoms of allergic conjunctivitis include red or pink eyes, pain, itchiness, swollen eyelids and soreness. Diagnostic tests of allergic conjunctivitis include an allergy skin test, a blood test and a scraping of conjunctival tissue may be taken to examine your white blood cells.
Drug treatment includes antihistamines, mast cell stabilizers, and occasionally, corticosteroids. Antihistamines may help bring fast relief from symptoms. The companies active in development of Allergic Conjunctivitis Drugs are Aldeyra Therapeutics, Inc., Inmunotek, Regeneron Pharmaceuticals, Vanda Pharmaceuticals, and Santen Pharmaceutical Co., Ltd.
Read more about Allergic Conjunctivitis - Drug Pipeline here: https://www.globalinsightservices.com/reports/allergic-conjunctivitis-drug-pipeline-landscape/
There are many clinical trials currently ongoing in Allergic Conjunctivitis Drug Development. Some of the most promising and well-designed trials are studying new medications and treatments for allergic conjunctivitis. These trials are testing the safety and effectiveness of these new medications and treatments, and they hold the potential to improve the quality of life for people with allergic conjunctivitis.
Report Highlights:
Global Insight Service's, Allergic Conjunctivitis - Drug Pipeline Landscape, 2023 report provides an overview of the Allergic conjunctivitis pipeline drugs. This report covers detailed insights on Allergic Conjunctivitis drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Allergic Conjunctivitis pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS31211
Methodology:
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Scope:
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
Major pharmaceutical companies are involved in the development of potential drug candidates to improve the Allergic Conjunctivitis treatment such as REGN1908-1909, Reproxalap, VSJ-110 and others. Key players involved in the development of therapies to treat Allergic Conjunctivitis are Aldeyra Therapeutics, Inc, Allakos, Inmunotek, Regeneron Pharmaceuticals, Vanda Pharmaceuticals and others. Five drugs are under late-stage Phase III clinical trials and one drug is in Phase II clinical trials and some other drugs are under Phase I clinical stages of development.
For In-Depth Competitive Analysis, Purchase this Report: https://www.globalinsightservices.com/checkout/single_user/GIS31211/
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Allergic Conjunctivitis - Drug Pipeline Landscape, 2023 | Aldeyra Therapeutics, Allakos, Inmunotek, Regeneron Pharmaceuticals here
News-ID: 2929458 • Views: …
More Releases from Global Insight Services
Supply Chain Security Market Expected to Grow from $4.8 Billion in 2024 to $12.3 …
The Supply Chain Security Market has become a cornerstone of global commerce as organizations increasingly recognize the need to safeguard their supply chains from disruptions, cyber threats, and operational vulnerabilities. This market encompasses an array of solutions, technologies, and services designed to protect the integrity and resilience of supply networks. From risk management and compliance tools to cargo tracking and cybersecurity solutions, the Supply Chain Security Market ensures that businesses…
Vertical Turbine Pumps Market Expected to Grow from $2.9 Billion in 2024 to $5.4 …
The Vertical Turbine Pumps Market is a crucial segment of the global fluid management industry, primarily focusing on pumps designed to lift water from deep wells or reservoirs. These pumps, distinguished by their vertical configuration, ensure efficient water distribution across agricultural, municipal, and industrial applications. With growing global water demand, technological advancements, and an emphasis on sustainable water management, the market is witnessing robust expansion. Rising infrastructure development and urbanization…
RFID Printers Market rising from $1.8 Bn to $3.2 Bn (2034), CAGR 5.9%. Key Playe …
Market Overview
RFID Printers Market is witnessing rapid growth as industries increasingly adopt advanced identification and tracking solutions. RFID (Radio Frequency Identification) printers enable organizations to encode and print data on RFID tags, revolutionizing asset tracking, inventory management, and supply chain operations. This technology supports key sectors such as retail, healthcare, logistics, and manufacturing, allowing seamless data capture and real-time visibility. As digital transformation accelerates globally, the RFID Printers Market is…
PVC Coated Woven Fabrics Market to grow from $3.5 Bn (2024) to $6.8 Bn (2034) at …
Market Overview
PVC Coated Woven Fabrics Market is experiencing significant growth, driven by increasing demand for durable, water-resistant, and versatile materials across various industries. These fabrics, coated with polyvinyl chloride, offer exceptional strength, flexibility, and weather resistance, making them ideal for use in automotive interiors, industrial tarpaulins, construction materials, and outdoor furniture. As industries worldwide prioritize sustainability and performance, the PVC Coated Woven Fabrics Market is witnessing a surge in innovative…
More Releases for Allergic
Prominent Allergic Rhinitis Market Trend for 2025: Advancements In Treating Nasa …
Which drivers are expected to have the greatest impact on the over the allergic rhinitis market's growth?
Anticipated growth in the allergic rhinitis market is predicted to be driven by increasing levels of air pollution and the impact of climate change. The term air pollution denotes the existence of harmful substances in our planet's atmosphere, which can negatively impact human health, damage the environment, and reduce the air's quality. Climate change…
Allergic Rhinitis: A Comprehensive Overview
Allergic rhinitis, commonly known as hay fever, is a condition where an individual's immune system overreacts to allergens in the air. These allergens, which may include pollen, dust, or pet dander, trigger inflammation inside the nose, leading to symptoms like sneezing, a runny nose, itchy eyes, and congestion. While often associated with the spring and fall seasons due to pollen levels, allergic rhinitis can affect individuals year-round, depending on the…
Allergic Conjunctivitis Market Statistics, Growth | Forecast
The new report published by The Business Research Company, titled ""Allergy Conjunctivitis Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the allergy conjunctivitis market size has grown strongly in recent years. It will grow from $2.4 billion in 2023…
Anti-Allergic Drugs Market Overview 2030
Anti-allergic drugs represent a pivotal domain in healthcare, providing advanced solutions to alleviate symptoms triggered by allergens. With an ever-growing prevalence of allergies globally, the anti-allergic drugs market is witnessing a significant surge. Valued at USD 26,234 Million in 2021, the market is poised to skyrocket to USD 47,566 Million by 2030, showcasing a robust CAGR of 6.8%. In the United States alone, where allergies affect 40 to 50 million…
Allergic Conjunctivitis Market - Clear Eyes, Allergy-Free: Allergic Conjunctivit …
Newark, New Castle, USA: The "Allergic Conjunctivitis Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Allergic Conjunctivitis Market: https://www.growthplusreports.com/report/allergic-conjunctivitis-market/7892
This latest report researches the industry structure, sales, revenue,…
Allergic Conjunctivitis Market - Empowering Eyes, Enhancing Lives: Redefining Al …
Newark, New Castle, USA - new report, titled Allergic Conjunctivitis Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Allergic Conjunctivitis market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Allergic Conjunctivitis market. The report offers an overview of the market, which…
